CARDINAL HEALTH INC - Common Stock (CAH)

Historical Holders from Q1 2014 to Q4 2025

Type / Class: Equity / Common Stock
Symbol: CAH on NYSE
Shares outstanding: 238,949,120
Price per share: $205.50
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 205,499,843
Holdings value: $32,209,908,763
% of all portfolios: 0.02%
Share change: +737,941
Value change: +$33,285,791
Average buys %: +0%
Average sells %: -0.01%
Number of holders: 1,204
Price from insider filings: $212.26

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CARDINAL HEALTH INC - Common Stock (CAH) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	7.8%		$2,449,171,616		18,774,792		BlackRock, Inc.	31 Jan 2025
BlackRock Portfolio Management LLC	5%	+6%	$1,875,272,694	+$102,944,413	11,947,456	+5.8%	BlackRock Portfolio Management LLC	30 Sep 2025

As of 30 Sep 2025, CARDINAL HEALTH INC - Common Stock (CAH) has 1,204 institutional shareholders filing 13F forms. They hold 205,499,843 shares of 238,949,120 outstanding shares (86%) .

Top 25 institutional shareholders own 57% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
BlackRock, Inc.	13%	31,464,655	+3%	0.09%	$4,938,692,215
VANGUARD GROUP INC	13%	30,823,483	+0.81%	0.07%	$4,838,053,892
STATE STREET CORP	5.1%	12,287,733	-3%	0.07%	$1,928,682,572
GEODE CAPITAL MANAGEMENT, LLC	2.7%	6,485,089	+1.5%	0.06%	$1,013,908,455
WELLINGTON MANAGEMENT GROUP LLP	2.4%	5,804,090	+153%	0.16%	$911,009,966
FMR LLC	2.3%	5,420,038	-14%	0.04%	$850,729,387
MORGAN STANLEY	2.2%	5,230,317	-4.4%	0.05%	$820,950,734
BANK OF AMERICA CORP /DE/	1.5%	3,592,775	+3.2%	0.04%	$563,921,919
Invesco Ltd.	1.5%	3,483,207	+15%	0.09%	$546,724,207
NORTHERN TRUST CORP	1.2%	2,926,088	-2.3%	0.06%	$459,278,772
JPMORGAN CHASE & CO	1.2%	2,898,738	+15%	0.03%	$454,986,109
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC	1.1%	2,515,013	-2.5%	0.09%	$394,756,442
VICTORY CAPITAL MANAGEMENT INC	0.96%	2,284,115	+45%	0.22%	$352,164,513
Legal & General Group Plc	0.89%	2,138,565	-9%	0.08%	$335,669,166
MILLENNIUM MANAGEMENT LLC	0.83%	1,984,424	+55%	0.25%	$311,475,191
GOLDMAN SACHS GROUP INC	0.83%	1,977,614	+24%	0.04%	$310,406,351
PRICE T ROWE ASSOCIATES INC /MD/	0.82%	1,967,697	+21%	0.03%	$308,851,000
BNP PARIBAS FINANCIAL MARKETS	0.82%	1,956,749	0%	0.24%	$307,131,323
Holocene Advisors, LP	0.81%	1,926,170	+141%	0.69%	$302,331,643
Man Group plc	0.67%	1,605,349	+26%	0.49%	$251,975,579
BARCLAYS PLC	0.66%	1,584,214	+109%	0.09%	$248,658,229
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.65%	1,552,347	+2%	0.04%	$243,656,385
AMERIPRISE FINANCIAL INC	0.61%	1,455,196	+33%	0.05%	$228,466,974
Bank of New York Mellon Corp	0.6%	1,440,898	-2.2%	0.04%	$226,163,427
Qube Research & Technologies Ltd	0.58%	1,374,083	-3.2%	0.31%	$215,676,068

Institutional Holders of CARDINAL HEALTH INC - Common Stock (CAH) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	1,803,071	$371,753,420	+$247,533,435			$205.50	49
2025 Q3	205,499,843	$32,209,908,763	+$33,285,791	$283,145,152	$334,366,215	$156.96	1,204
2025 Q2	204,989,696	$34,414,795,368	+$96,702,635	$308,693,232	$331,898,162	$168.00	1,238
2025 Q1	204,977,020	$28,223,765,866	-$604,518,873	$389,891,564	$281,967,893	$137.77	1,131
2024 Q4	209,491,043	$24,785,262,719	-$38,257,028	$199,408,703	$231,594,599	$118.27	1,077
2024 Q3	208,059,322	$22,992,632,351	-$620,109,288	$107,650,115	$213,438,763	$110.52	1,006
2024 Q2	212,765,611	$20,912,785,889	-$60,109,113	$86,128,320	$164,961,296	$98.32	991
2024 Q1	213,554,257	$23,884,544,630	+$262,083,977	$129,736,860	$208,731,070	$111.90	1,045
2023 Q4	1,275,417	$128,562,637	+$9,638,780			$100.80	20
2023 Q3	211,442,133	$18,376,865,026	-$363,179,240	$170,928,534	$220,108,018	$86.82	925
2023 Q2	211,048,618	$19,961,305,733	-$429,477,350	$211,112,094	$300,741,450	$94.57	921
2023 Q1	220,589,135	$16,668,084,189	-$170,122,694	$99,065,450	$264,172,400	$75.50	885
2022 Q4	223,553,471	$17,190,935,385	-$828,363,917	$139,882,802	$175,704,213	$76.87	909
2022 Q3	234,107,244	$15,638,966,776	+$218,052,203	$143,053,228	$242,439,000	$66.68	816
2022 Q2	230,850,801	$12,064,802,517	-$7,984,176	$54,287,016	$99,255,164	$52.27	766
2022 Q1	229,843,514	$13,050,668,369	-$60,965,398	$126,527,082	$163,441,713	$56.70	753
2021 Q4	233,030,375	$12,009,888,965	-$380,772,045	$133,657,000	$196,409,000	$51.49	752
2021 Q3	240,141,821	$11,889,942,959	-$186,312,317	$112,356,000	$114,849,000	$49.46	722
2021 Q2	243,485,463	$13,906,755,381	+$73,977,279	$99,989,000	$170,836,000	$57.09	766
2021 Q1	240,871,247	$14,638,269,133	-$144,714,373	$77,780,000	$102,616,000	$60.75	779
2020 Q4	242,612,910	$12,999,755,086	-$1,759,659	$112,995,381	$90,967,444	$53.56	750
2020 Q3	246,828,992	$11,593,321,393	-$185,531,919	$114,887,237	$98,289,000	$46.95	713
2020 Q2	245,675,701	$12,823,943,943	+$80,285,486	$108,616,000	$120,271,000	$52.19	739
2020 Q1	247,259,407	$11,868,114,399	-$429,926,777	$100,742,000	$59,982,000	$47.94	690
2019 Q4	257,514,040	$13,029,480,314	-$299,627,787	$127,816,000	$109,574,000	$50.58	685
2019 Q3	261,661,077	$12,355,866,624	-$145,072,710	$129,054,000	$82,952,000	$47.19	637
2019 Q2	264,680,605	$12,472,920,009	+$263,832,854	$104,119,000	$77,372,000	$47.10	663
2019 Q1	264,893,586	$12,762,699,201	+$227,175,372	$56,992,000	$73,914,000	$48.15	674
2018 Q4	259,849,285	$11,596,425,704	-$313,624,639	$59,565,000	$101,039,000	$44.60	685
2018 Q3	268,396,379	$14,490,993,642	-$285,998,348	$69,872,000	$61,132,000	$54.00	670
2018 Q2	274,274,293	$13,393,887,150	-$659,802,905	$72,923,000	$40,973,000	$48.83	689
2018 Q1	288,534,394	$18,083,881,921	+$328,383,529	$63,625,156	$60,275,013	$62.68	722
2017 Q4	270,732,381	$16,588,697,090	+$60,220,041	$79,136,011	$50,990,011	$61.27	701
2017 Q3	277,070,856	$18,540,414,745	-$32,937,408	$52,586,000	$43,485,000	$66.92	692
2017 Q2	276,900,607	$21,577,039,049	+$205,157,514	$28,052,002	$58,418,004	$77.92	733
2017 Q1	270,965,161	$22,093,938,655	+$1,489,665,643	$35,474,009	$43,135,036	$81.55	750
2016 Q4	279,231,944	$20,105,310,706	+$269,884,407	$32,150,008	$44,744,000	$71.97	762
2016 Q3	273,765,875	$21,257,080,439	-$23,013,475	$65,612,000	$85,761,000	$77.70	756
2016 Q2	277,401,976	$21,651,977,127	-$219,549,377	$27,598,000	$49,114,000	$78.01	797
2016 Q1	276,913,261	$22,687,848,914	-$439,324,977	$38,318,000	$35,153,000	$81.95	782
2015 Q4	282,441,678	$25,198,709,280	-$439,472,144	$37,528,000	$57,748,000	$89.27	778
2015 Q3	284,534,569	$21,858,671,378	+$97,296,145	$71,822,000	$38,143,000	$76.82	748
2015 Q2	281,530,186	$23,551,629,171	-$91,602,794	$35,677,000	$39,543,000	$83.65	755
2015 Q1	287,330,619	$25,925,498,211	+$356,341,597	$29,426,000	$38,127,000	$90.27	725
2014 Q4	283,849,088	$22,922,393,596	-$680,746,811	$81,524,000	$31,380,000	$80.73	697
2014 Q3	291,352,150	$21,828,134,024	-$101,378,849	$50,750,000	$43,704,000	$74.92	630
2014 Q2	292,833,962	$20,080,629,867	+$130,395,586	$60,246,000	$54,223,000	$68.56	629
2014 Q1	290,954,890	$20,357,443,922	-$356,740,512	$43,242,000	$54,435,000	$69.98	638